Literature DB >> 18625436

Host genetic factors and antiviral immune responses to hepatitis C virus.

Chloe L Thio1.   

Abstract

Human genome variations explain some of the heterogeneity in the immune response to antigenic stimuli. Such differences in response to hepatitis C virus (HCV) antigens can account for the ability of the immune response to clear HCV after an acute infection or to develop more rapidly progressive liver disease. Several studies have examined polymorphisms in several candidate immune-response genes for their relation to these HCV outcomes. Results of some of these studies complement knowledge gained from immunology studies, and others offer new insights into HCV biology. This review summarizes published studies on variation in immune-response genes and HCV outcomes.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18625436      PMCID： PMC2597299          DOI： 10.1016/j.cld.2008.03.002

Source DB:  PubMed          Journal:  Clin Liver Dis        ISSN： 1089-3261            Impact factor:   6.126


  75 in total

Review 1.  The liver as an immunological organ.

Authors:  Vito Racanelli; Barbara Rehermann
Journal:  Hepatology       Date:  2006-02       Impact factor: 17.425

2.  Human leukocyte antigen class II DQB1*0301, DRB1*1101 alleles and spontaneous clearance of hepatitis C virus infection: a meta-analysis.

Authors:  Xin Hong; Rong-Bin Yu; Nan-Xiong Sun; Bin Wang; Yao-Chu Xu; Guan-Ling Wu
Journal:  World J Gastroenterol       Date:  2005-12-14       Impact factor: 5.742

3.  Studies on TAQ1 polymorphism in the 3'untranslated region of IL-12P40 gene in HCV patients infected predominantly with genotype 3.

Authors:  P V Suneetha; A Goyal; S S Hissar; S K Sarin
Journal:  J Med Virol       Date:  2006-08       Impact factor: 2.327

4.  The CCR5-delta32 mutation: impact on disease outcome in individuals with hepatitis C infection from a single source.

Authors:  C Goulding; R McManus; A Murphy; G MacDonald; S Barrett; J Crowe; J Hegarty; S McKiernan; D Kelleher
Journal:  Gut       Date:  2005-04-29       Impact factor: 23.059

5.  Identification of two gene variants associated with risk of advanced fibrosis in patients with chronic hepatitis C.

Authors:  Hongjin Huang; Mitchell L Shiffman; Ramsey C Cheung; Thomas J Layden; Scott Friedman; Olivia T Abar; Linda Yee; Anand P Chokkalingam; Steven J Schrodi; Jason Chan; Joseph J Catanese; Diane U Leong; David Ross; Xiaolan Hu; Alexander Monto; Linda B McAllister; Samuel Broder; Thomas White; John J Sninsky; Teresa L Wright
Journal:  Gastroenterology       Date:  2006-03-06       Impact factor: 22.682

6.  Interleukin-10 or tumor necrosis factor-alpha polymorphisms and the natural course of hepatitis C virus infection in a hyperendemic area of Japan.

Authors:  Kazunori Kusumoto; Hirofumi Uto; Katsuhiro Hayashi; Yuka Takahama; Hiroyuki Nakao; Robert Suruki; Sherri O Stuver; Akio Ido; Hirohito Tsubouchi
Journal:  Cytokine       Date:  2006-05-15       Impact factor: 3.861

7.  HLA class I allelic diversity and progression of fibrosis in patients with chronic hepatitis C.

Authors:  Keyur Patel; Suzanne Norris; Lauralynn Lebeck; Anne Feng; Michael Clare; Stephen Pianko; Bernard Portmann; Lawrence M Blatt; James Koziol; Andrew Conrad; John G McHutchison
Journal:  Hepatology       Date:  2006-02       Impact factor: 17.425

8.  Lack of chemokine receptor CCR5 promotes murine fulminant liver failure by preventing the apoptosis of activated CD1d-restricted NKT cells.

Authors:  Maureen N Ajuebor; Alex I Aspinall; Feng Zhou; Tai Le; Yang Yang; Stefan J Urbanski; Stéphané Sidobre; Mitchell Kronenberg; Cory M Hogaboam; Mark G Swain
Journal:  J Immunol       Date:  2005-06-15       Impact factor: 5.422

9.  Association of transforming growth factor-beta 1 functional polymorphisms with natural clearance of hepatitis C virus.

Authors:  Tomomi Kimura; Takafumi Saito; Mika Yoshimura; Song Yixuan; Masanori Baba; Guijin Ji; Masaaki Muramatsu; Sumio Kawata
Journal:  J Infect Dis       Date:  2006-04-05       Impact factor: 5.226

10.  Divergent and convergent evolution after a common-source outbreak of hepatitis C virus.

Authors:  Stuart C Ray; Liam Fanning; Xiao-Hong Wang; Dale M Netski; Elizabeth Kenny-Walsh; David L Thomas
Journal:  J Exp Med       Date:  2005-06-06       Impact factor: 14.307
View more
  29 in total

1.  Specific human leukocyte antigen class I and II alleles associated with hepatitis C virus viremia.

Authors:  Mark H Kuniholm; Andrea Kovacs; Xiaojiang Gao; Xiaonan Xue; Darlene Marti; Chloe L Thio; Marion G Peters; Norah A Terrault; Ruth M Greenblatt; James J Goedert; Mardge H Cohen; Howard Minkoff; Stephen J Gange; Kathryn Anastos; Melissa Fazzari; Tiffany G Harris; Mary A Young; Howard D Strickler; Mary Carrington
Journal:  Hepatology       Date:  2010-05       Impact factor: 17.425

Review 2.  Host genetic basis for hepatitis C virus clearance: a role for blood collection centers.

Authors:  Suganya Selvarajah; Leslie H Tobler; Graham Simmons; Michael P Busch
Journal:  Curr Opin Hematol       Date:  2010-11       Impact factor: 3.284

3.  A case-control study of factors associated with resolution of hepatitis C viremia in former blood donors (CME).

Authors:  Leslie H Tobler; Shrein H Bahrami; Zhanna Kaidarova; Lubov Pitina; Valarie K Winkelman; Sandra K Vanderpool; Anne M Guiltinan; Stewart Cooper; Michael P Busch; Edward L Murphy
Journal:  Transfusion       Date:  2010-03-25       Impact factor: 3.157

4.  Zika Virus Infects Human Placental Macrophages.

Authors:  Kendra M Quicke; James R Bowen; Erica L Johnson; Circe E McDonald; Huailiang Ma; Justin T O'Neal; Augustine Rajakumar; Jens Wrammert; Bassam H Rimawi; Bali Pulendran; Raymond F Schinazi; Rana Chakraborty; Mehul S Suthar
Journal:  Cell Host Microbe       Date:  2016-05-27       Impact factor: 21.023

5.  Combined effect of pro- and anti-inflammatory cytokine gene polymorphisms on susceptibility to liver cirrhosis in Tunisian HCV-infected patients.

Authors:  Nadia Bouzgarrou; Elham Hassen; Olfa Bahri; Sallouha Gabbouj; Nabil Ben Mami; Henda Triki; Lotfi Chouchane
Journal:  Hepatol Int       Date:  2011-02-08       Impact factor: 6.047

6.  A multifaceted computational report on the variants effect on KIR2DL3 and IFNL3 candidate gene in HCV clearance.

Authors:  Pratichi Singh; J Febin Prabhu Dass
Journal:  Mol Biol Rep       Date:  2016-07-26       Impact factor: 2.316

Review 7.  Hepatitis C virus in the new era: perspectives in epidemiology, prevention, diagnostics and predictors of response to therapy.

Authors:  Filippo Ansaldi; Andrea Orsi; Laura Sticchi; Bianca Bruzzone; Giancarlo Icardi
Journal:  World J Gastroenterol       Date:  2014-08-07       Impact factor: 5.742

8.  The relation of HLA genotype to hepatitis C viral load and markers of liver fibrosis in HIV-infected and HIV-uninfected women.

Authors:  Mark H Kuniholm; Xiaojiang Gao; Xiaonan Xue; Andrea Kovacs; Darlene Marti; Chloe L Thio; Marion G Peters; Ruth M Greenblatt; James J Goedert; Mardge H Cohen; Howard Minkoff; Stephen J Gange; Kathryn Anastos; Melissa Fazzari; Mary A Young; Howard D Strickler; Mary Carrington
Journal:  J Infect Dis       Date:  2011-06-15       Impact factor: 5.226

9.  Polymorphisms in EGFR and IL28B are associated with spontaneous clearance in an HCV-infected Iranian population.

Authors:  R Carapito; H Poustchi; M Kwemou; M Untrau; A H Sharifi; S Merat; A Haj-Sheykholeslami; H Jabbari; S Esmaili; S Michel; J Toussaint; M Le Gentil; A Ansari-Moghaddam; M Radosavljevic; A Etemadi; P Georgel; R Malekzadeh; S Bahram
Journal:  Genes Immun       Date:  2015-09-17       Impact factor: 2.676

10.  Interleukin 28B Polymorphisms and Hepatitis C-Translating the Association into Clinical Decision Making.

Authors:  Col Pankaj Puri
Journal:  J Clin Exp Hepatol       Date:  2011-08-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.